Pharma Deals Half-Year Review of 2025

FierceBiotechAstraZeneca plucks preclinical EGFR degrader from Pinetree for $25M

Novo NordiskIs Novo Nordisk's GLP-1 dominance fading after Lilly's clinical wins? - MSN

Siemens HealthineersSiemens Healthineers: A €6 Billion Diagnostics Exit and a Coming Spin-Off as Shares Hit Rock Botto - AD HOC NEWS

BioPharma DiveAvalyn, in pursuit of better lung drugs, banks $300M in an IPO

Insilico MedicineInsilico Medicine Secures IND Clearance For Rentosertib Inhalation Solution To Advance Targeted IPF Therapy - BioPharma APAC

MedtronicMedtronic Advances First Clinical Cases with Stealth AXiS™ Surgical System, Demonstrating the Power of Connected Smart Ecosystems Across Neurosurgery - Orthopedics This Week

Boston ScientificBoston Scientific Corporation (BSX): Stephen Mandel Opens New Position in Medical Device Firm - Yahoo Finance

10x Genomics NewsVanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan

10x Genomics Blog10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan

10x Genomics News10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - PR Newswire

10x Genomics Blog10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Yahoo Finance UK

FierceBiotechFDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death